Bayforest Capital LTD Biomarin Pharmaceutical Inc Transaction History
Bayforest Capital LTD
- $121 Billion
- Q1 2025
A detailed history of Bayforest Capital LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Bayforest Capital LTD holds 7,808 shares of BMRN stock, worth $484,564. This represents 0.22% of its overall portfolio holdings.
Number of Shares
7,808Holding current value
$484,564% of portfolio
0.22%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
648Shares Held
184MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.41 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.18 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.1 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$915 Million0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$806 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.5B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...